Find News

Filter articles

Showing 3131 to 3140 of 3671 results

Novartis pays Juno $12m in cancer patent licensing deal

US07-04-2015Legal developments

US anti-cancer company Juno Therapeutics and a children’s hospital have settled their patent licensing suit with pharmaceutical business Novartis and the trustees of the University of Pennsylvania.

Kramer Levin expands life sciences practice with two hires


Law firm Kramer Levin Naftalis & Frankel has hired life sciences attorneys Brian Slater and Gregory Sephton.

Schiff Hardin welcomes counsel to Chicago team


Law firm Schiff Hardin has added Cindy Ahn as counsel in its intellectual property practice group.

Forest files fifth patent lawsuit to protect Viibryd


Forest Labs, a subsidiary of Actavis, has sued InvaGen for allegedly infringing four patents covering depression drug Viibryd, in what is the fifth related lawsuit.

Federal Circuit revives Apotex blood pressure case


A US appeals court has overturned a district court's decision to deny Apotex's request for a declaratory judgment that its proposed generic blood pressure drug would not infringe a patent owned by pharmaceutical company Daiichi Sankyo.

Indian government ‘considers extending’ data exclusivity term


The Indian government is “seriously considering” extending the term of data exclusivity protection for agrochemical inventions from three to five years, it has been claimed.

Purdue moves to block oxycodone drug


Purdue Pharma has sued Collegium Pharmaceutical for allegedly infringing four of its patents relating to extended release painkiller OxyContin.

Amgen dealt blow as FDA rules 'patent dance' optional


The US Food and Drug Administration has denied Amgen’s petition asking that the so-called patent dance between a biosimilar maker and the product’s innovator be a mandatory requirement.

EPO approves patents in Tomato II and Broccoli II cases


An appeals board at the European Patent Office has said that any patent applications covering a “product-by-process” method for developing plants can be granted.

Hospira targeted in generic Aloxi patent infringement case


Cancer treatment company Helsinn and pharmaceutical company Roche have sued Hospira for allegedly infringing five patents covering intravenous anti-nausea drug Aloxi.

Showing 3131 to 3140 of 3671 results